Showing 1 - 2 results of 2 for search 'Tobias Herold', query time: 0.01s Refine Results
  1. 1
    X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

    X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL by Michela Carlet, Karin Schmelz, Jenny Vergalli, Tobias Herold, Daniela Senft, Vindi Jurinovic, Thomas Hoffmann, Jutta Proba, Nina Weichert, Christian Junghanß, Mareike Roth, Georg Eschenburg, Malwine Barz, Günter Henze, Cornelia Eckert, Angelika Eggert, Johannes Zuber, Patrick Hundsdoerfer, Irmela Jeremias

    Published 2022-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups

    Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups by Ricarda Knabe, Philippe Muller, Christoph Schliemann, Maher Hanoun, Julia Marie Unglaub, Barbora Weinbergerová, Jiří Mayer, Carolin Krekeler, Stefan W. Krause, Martin Kaufmann, Sabrina Kraus, Björn Steffen, Franziska Modemann, Marion Subklewe, Veit Bücklein, Wolfgang G. Kunz, Martina Rudelius, Michael von Bergwelt-Baildon, Katja Gutmair, Eva Hoster, Tobias Herold, Christoph Röllig, Karsten Spiekermann

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: